News Conference News TCT 2019 LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD L.A. McKeown September 28, 2019
News Conference News TCT 2018 Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released Todd Neale September 24, 2018
News Conference News TCT 2018 IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease Todd Neale September 22, 2018
Presentation TCT 2018 IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions Presenter: William A. Gray September 22, 2018
News Conference News TCT 2016 ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions L.A. McKeown November 07, 2016
News Features TCT 2014 Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease Todd Neale October 31, 2014
Presentation TCT 2013 Stenting Is the First-line Treatment for SFA Disease! Presenter: J. Michael Bacharach October 27, 2013
Presentation TCT 2012 Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem? Presenter: Eugenio Stabile October 22, 2012
Presentation TCT 2012 Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro! Presenter: Gary Ansel October 22, 2012
Presentation TCT 2012 Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con! Presenter: Lawrence Garcia October 22, 2012
News Conference News COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions Jason Kahn November 30, 2011